Sulphur-containing derivatives structurally related to fenoxycarb are potent growth inhibitors against the intracellular form of Trypanosoma cruzi

International Journal of Antimicrobial Agents

Volumn 13, Issue 3, 2000, Pages 215-218

  Rodriguez, Juan B ^a   Docampo, Roberto ^b   Gros, Eduardo G ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Amastigotes; Antiparasitic agents; Growth inhibitors; Trypanosoma cruzi

Indexed keywords

CARBAMIC ACID DERIVATIVE; FENOXYCARB; GROWTH INHIBITOR; SULFUR DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG ACTIVITY; EPIMASTIGOTE; NONHUMAN; PARASITE CONTROL; PRIORITY JOURNAL; STEROL SYNTHESIS; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; TRYPOMASTIGOTE;

ANIMALS; CARBAMATES; CELLS, CULTURED; PHENYL ETHERS; PHENYLCARBAMATES; STRUCTURE-ACTIVITY RELATIONSHIP; SULFIDES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 0033990258     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00125-9     Document Type: Article

References (40)

1. Tropical Disease Research, Thirteenth Programme Report, UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases. 1997;World Health Organization, Geneva.
2. Moncayo A. In: Eleventh Programme Report of the UNPD/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR). 1993;67-75 World Health Organization, Geneva.
3. Brener Z. Biology of Trypanosoma cruzi. Annu. Rev. Microbiol. 27:1973;347-382.
4. De Souza W. Cell biology of Trypanosoma cruzi. Int. Rev. Cytol. 86:1984;197-283.
5. De Castro S.L. The challenge of Chagas' disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Trop. 53:1993;83-98.
6. Rodriguez J.B., Gros E.G. Recent developments in the control of Trypanosoma cruzi, the causative agent for Chagas' disease. Curr. Med. Chem. 2:1995;723-749.
7. Taylor M.B., Gutteridge W.E. Trypanosoma cruzi: subcellular distribution of glycolytic and some related enzymes of epimastigotes. Exp. Parasitol. 63:1987;84-97.
8. Fairlamb A.H., Cerami A. Metabolism and functions of trypanothione in the Kinetoplastida. Annu. Rev. Microbiol. 46:1992;695-729.
9. Aronov A.M., Verlinde C.L.M.J., Hol W.G.I. et al. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design. J. Med. Chem. 41:1998;4790-4799.
10. Urbina J.A. Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites. Parasitology. 114:1997;91-99.
11. Yokoyama K., Trobridge P., Buckner F.S. et al. The effects of protein farnesyltransferase inhibitors on trypanosomatids: inhibition of protein farnesylation and cell growth. Mol. Biochem. Parasitol. 94:1998;87-97.
12. Marr J.J., Docampo R. Chemotherapy for Chagas' disease: a perspective of current therapy and considerations for future research. Rev. Infect. Dis. 8:1986;884-903.
13. Gutteridge W.E. Existing chemotherapy and its limitations. Br. Med. Bull. 41:1985;162-168.
14. Neal R.A., van Bueren J. Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vivo and in vitro. Trans. R. Soc. Trop. Med. Hyg. 82:1988;709-714.
15. Filardi L.S., Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans. R. Soc. Trop. Med. Hyg. 81:1987;755-759.
16. Murta S.M., Romanha A.J. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole. Parasitology. 116:1998;165-171.
17. Nozaki T., Engel J., Dvorak J. Cellular and molecular biological analyses of nifurtimox resistance in Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 55:1996;111-117.
18. Nussenzweig V., Sonntag R., Biancalana A. et al. Acão de corantes trifenil-metanicos sobre o Trypanosoma cruzi in vitro. Emprêgo de violeta de genciana na profilaxia da transmissão da moléstia de Chagas por transfusão de sangue. Hospital (Rio de Janeiro). 44:1953;731-744.
19. Docampo R., Moreno S.N.J. Biochemical toxicology of antiparasitic compounds used in the chemotherapy and chemoprophylaxis of American Trypanosomiaisis (Chagas' disease). Rev. Biochem. Toxicol. 7:1985;159-204.
20. Kirchhoff L.V. American Trypanosomiasis (Chagas' disease). A tropical disease now in the US. N. Engl. J. Med. 329:1993;639-644.
21. Galel S.A., Kirchhoff L.V. Risk factors for Trypanosoma cruzi infection in California blood donors. Transfusion. 36:1996;227-231.
22. Shulman I.A., Appleman M.D., Saxena S. et al. Specific antibodies to Trypanosoma cruzi among blood donors in Los Angeles, CA. Transfusion. 37:1997;727-731.
23. Leiby D.A., Read E.J., Lenes B.A. et al. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors. J. Infect. Dis. 176:1997;1047-1052.
24. Docampo R., Schmuñis G.A. Sterol biosynthesis inhibitors: potential chemotherapeutics against Chagas disease. Parasitol. Today. 13:1997;129-130.
25. Urbina J.A., Payares G., Molina J. et al. Cure of short- and long-term experimental Chagas' disease using D0870. Science. 273:1996;969-971.
26. Urbina J.A., Payares G., Contreras L.M. et al. Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob. Agents Chemother. 42:1998;1771-1777.
27. Liendo A., Lazardi K., Urbina J.A. In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi. J. Antimicrob. Chemother. 41:1998;197-205.
28. Rodriguez J.B., Zhong L., Docampo R. et al. Biological evaluation of two potent inhibitors of Trypanosoma cruzi epimastigotes against the intracellular form of the parasite. Biomed. Chem. Lett. 6:1996;2783-2786.
29. Masner P., Dorn S., Vogel W. et al. Types of response of insects to a new insect growth regulators and to a proven standards. Pr. Nauk. Inst. Chem. Org. Fiz. Politech. Wroclaw. 22:1981;809-818.
30. Rodriguez J.B., Gros E.G., Stoka A.M. Synthesis and activity of juvenile hormone analogues (JHA) for Trypanosoma cruzi. Biomed. Chem. Lett. 1:1991;679-682.
31. Stoka A.M., Rivas C., Segura E. et al. Biological activity of synthetic juvenile hormone analogues for Trypanosoma cruzi. Z. Naturforsch. B. 45:1990;96-98.
32. Rodriguez J.B., Gros E.G., Stoka A.M. Synthesis and activity of juvenile hormone analogues (JHA). Z. Naturforsch. B. 43:1988;1038-1042.
33. Rodriguez J.B., Gros E.G., Stoka A.M. Synthesis and activity of juvenile hormone analogues (JHA). Part II. Z. Naturforsch. B. 44:1989;983-987.
34. Perlawagora-Szumlewicz A., Petana W.P., Figueiredo M.J. The evaluation of host efficiency and vector potential of laboratory juvenilized vector of Chagas' disease. I - Effects of developmental changes induced by juvenile hormone analogues in Pantrongylus megistus (Hemiptera-Reduviidae) on the susceptibility of insects to gut infection with Trypanosoma cruzi. Rev. Inst. Med. Trop. 17:1975;97-102.
35. Vladusic E.A., Bussmann L.E., Visconti P.E. et al. Effect of juvenile hormone on mammalian steroidogenesis. J. Steroid Biochem. Mol. Biol. 50:1994;81-187.
36. Vladusic E.A., Pignataro O.P., Bussmann L.E. et al. Regulation of the cholesterol ester cycle and progesterone synthesis by juvenile hormone in MA-10 Leydig tumor cells. J. Steroid Biochem. Mol. Biol. 52:1995;83-90.
37. Cinque G.M., Szajnman S.H., Zhong L. et al. Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi. J. Med. Chem. 41:1998;1540-1554.
38. Fichera L., Esteva M., Wimmer Z. et al. Effects of juvenile hormone analogues (JHA) on the development of Trypanosoma cruzi. Z. Naturforsch. C. 50:1995;578-580.
39. Schvartzapel A.J., Zhong L., Docampo R. et al. Design, synthesis and biological evaluation of new growth inhibitors of Trypanosoma cruzi (epimastigotes). J. Med. Chem. 40:1997;2314-2322.
40. Schvartzapel A.J., Fichera L., Esteva M. et al. Design, synthesis, and anti-Trypanosoma cruzi evaluation of a new class of cell growth inhibitors structurally related to fenoxycarb. Helv. Chim. Acta. 78:1995;1207-1214.